| 发明名称 |
BIOMARKERS FOR TREATMENT OF NEOPLASTIC DISORDERS USING ANDROGEN-TARGETED THERAPIES |
| 摘要 |
Described herein are methods and compositions for the treatment of prostate cancer in a subject in need thereof. The prostate cancer may be a castration resistant and an androgen receptor antagonist-resistant prostate cancer. The methods may comprise administering to the subject a CYP17-lyase inhibitor of Formula II. |
| 申请公布号 |
US2015374721(A1) |
申请公布日期 |
2015.12.31 |
| 申请号 |
US201514792490 |
申请日期 |
2015.07.06 |
| 申请人 |
Tokai Pharmaceuticals, Inc. |
发明人 |
Njar Vincent;Zoubeidi Amina;Ferrante Karen;Corey Eva;Jacoby Douglas |
| 分类号 |
A61K31/58 |
主分类号 |
A61K31/58 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
Boston MA US |
